If you need more lookups,
subscriptions start at $34 USD/month.
Helen Ho Location
Cambridge, MA, US
Helen Ho Work
Chief Business and Strategy Officer @ (January 2026 - Present)
Member, Board of Advisors @ (January 2023 - Present)
Chief Business Officer @ (January 2022 - January 2025)
SVP, Head of Corporate Development @ (January 2021 - January 2022)
Vice President, Head of Corporate Development @ (January 2018 - January 2021)
Board Observer @ (January 2022 - January 2025)
Vice President, Head of Corporate Development @ TCR² Therapeutics Inc. (January 2017 - January 2018)
Sr. Director, Head of Corporate Development @ TCR² Therapeutics Inc. (January 2016 - January 2017)
Director, Business Development and Operations @ (January 2014 - January 2016)
Associate Director, Business Development and New Product Planning @ (January 2012 - January 2014)
Sr. Manager, Business Development @ (January 2011 - January 2012)
Management Consultant, Life Sciences Practice @ (January 2007 - January 2011)
Helen Ho Education
Yale University
Doctor of Philosophy (Biology)
University Of California - Los Angeles
Bachelor of Science (Biochemistry)
Helen Ho Skills
Molecular Biology
Leadership
Business Strategy
Financial Modeling
Lifesciences
Management Consulting
Biotechnology
Pharmaceutical Industry
Biochemistry
Oncology
Business Development
Drug Development
Life Sciences
PowerPoint
Cell Biology
Business Analysis
Strategy
Biopharmaceuticals
Drug Discovery
Microsoft Excel
Sales
Research
Data Analysis
Technology Transfer
Helen Ho Summary
Helen Ho, based in Cambridge, MA, US, is currently a Chief Business and Strategy Officer at Parabilis Medicines. Helen Ho brings experience from previous roles at GBH and Blueprint Medicines. Helen Ho holds a Doctor of Philosophy in Biology @ Yale University. With a robust skill set that includes Molecular Biology, Leadership, Business Strategy, Financial Modeling, Lifesciences and more. Helen Ho has 3 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Helen Ho?
Find contact details for 700 million professionals.